Low dose methods for treating disorders in which TNF$G(A) activity is detrimental

Details for Australian Patent Application No. 2003301522 (hide)

International Classifications

Event Publications

10 June 2004 Complete Application Filed

Priority application(s): 60/421,262 24.10.02 US

17 June 2004 Application Open to Public Inspection

Published as AU-B-2003301522

9 June 2005 Amendment Made

The nature of the amendment is: Amend the invention title from Low dose methods for treating disorders in which TNF$G(A) activity is detrimental to Low dose methods for treating disorders in which TNFalpha activity is detrimental 2004

8 July 2010 Application Accepted

Published as AU-B-2003301522

5 August 2010 Corrigenda

Applications Accepted - Name Index Under the name Abbott Biotechnology Ltd, Application No. 2003301522, under INID (54) correct the title to read Low dose methods for treating disorders in which TNFalpha activity is detrimental

4 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.